Unregulated tariffs and the lack of low-cost benefit schemes drive up the price of medical aid premiums, causing patients to feel the pain
There’s good news and bad news when it comes to PMBs.
Private healthcare is meant to support public health, but it must be kept in check.
Many medical schemes rely on the ignorance of their members, who buy more expensive cover than they may need, for their very survival.
Prescribed minimum benefits are to be pain in full by medical aid schemes, but consumers and some medical practitioners don’t understand this law.
